- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | BAK |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United Kingdom | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.2B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | BAK |
|---|---|---|
| Price | $42.75 | $2.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $51.33 | $4.40 |
| AVG Volume (30 Days) | 451.6K | ★ 868.4K |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | $597,973,000.00 | ★ $13,841,708,237.00 |
| Revenue This Year | $61.60 | N/A |
| Revenue Next Year | $29.82 | $7.81 |
| P/E Ratio | $91.42 | ★ N/A |
| Revenue Growth | ★ 55.68 | N/A |
| 52 Week Low | $17.82 | $2.32 |
| 52 Week High | $44.42 | $5.10 |
Technical Indicators
Market Signals| Indicator | KNSA | BAK |
|---|---|---|
| Relative Strength Index (RSI) | 58.71 | 53.75 |
| Support Level | $39.16 | $2.82 |
| Resistance Level | $43.55 | $3.09 |
| Average True Range (ATR) | 1.47 | 0.10 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 71.10 | 66.30 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.